NCT02072525 - A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays | Biotech Hunter

Enrollment

359

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

June 2, 2015

Study Completion Date

June 2, 2015

Conditions

Meningococcal

Interventions

BIOLOGICAL

Menveo®

One dose administered intramuscularly (IM) in the upper left deltoid of the arm.

BIOLOGICAL

Boostrix®

One dose administered intramuscularly (IM) in the upper right deltoid of the arm.

BIOLOGICAL

Pneumovax 23®

One dose administered intramuscularly (IM) in the non-dominant deltoid of the arm.

BIOLOGICAL

Prevnar 13®

One dose administered intramuscularly (IM) in the non-dominant deltoid of the arm.

Trial Locations (1)

GSK Investigational Site, Sherbrooke